Skip to main content

Abstract

Neurological disorders are almost always associated with psychiatric symptoms because disrupting neural pathways disrupt the circuitry that underlies mental processes. Of all the psychiatric symptoms that neurological lesions can trigger, psychosis is perhaps the most confusing to the patient and alarming to the neurologist due to the seriousness of the symptoms that can range from delusions and hallucinations to bizarre behavior or harm to self or others. While some neurologists refer patients who develop psychotic symptoms to psychiatrists for management, others treat such patients themselves. However, as psychiatrists know well, the management of psychotic disorders goes beyond pharmacotherapy and requires a team approach that can provide the necessary psychosocial interventions and therapies. However, pharmacologic treatment of poor reality testing in psychosis is the most essential first step toward restoring mental and functional stability to a patient. In this chapter, an overview of the four generations of antipsychotics is provided for neurologists to enable them to initiate the treatment of psychosis in their neurological practice and refer the patient as needed for longer-term management in a psychiatric setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nasrallah HA, Tandon R. Classic antipsychotic medications. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed. Arlington: American Psychiatric Publishing; 2009. p. 533–54.

    Google Scholar 

  2. Rosenbaum JF, Arana GW, Hymann SE, et al. Handbook of psychiatric drug therapy. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  3. Nasrallah HA, Smeltzer DJ. Contemporary diagnosis and management of schizophrenia. Newtown: Hand- books in Healthcare Co; 2011.

    Google Scholar 

  4. Stahl SM. Antipsychotics. Carlsbad: NEI Press; 2008.

    Google Scholar 

  5. Kapur S, Seeman P. Does fast dissociation from dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry. 2001;158:360–9.

    Article  CAS  PubMed  Google Scholar 

  6. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry. 2004;65:267–72.

    Article  Google Scholar 

  7. Marder SR, Wirshing DA. Clozapine. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed. Arlington: American Psychiatric Publishing; 2009. p. 555–72.

    Google Scholar 

  8. Goff DC. Risperidone and paliperidone. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed. Arlington: American Psychiatric Publishing; 2009. p. 627–40.

    Google Scholar 

  9. Ballon JS, Wirshing DA, Schultz SC. Olanzapine. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed. Arlington: American Psychiatric Publishing; 2009. p. 573–98.

    Google Scholar 

  10. Buckley PF, Foster AE. Quetiapine. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed. Arlington: American Psychiatric Publishing; 2009. p. 599–612.

    Google Scholar 

  11. Newcomer JW, Fallucco EM. Ziprasidone. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed. Arlington: American Psychiatric Publishing; 2009. p. 641–68.

    Google Scholar 

  12. Sharif Z, Lieberman JA. Aripiprazole. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed. Arlington: AmericanPsychiatric Publishing; 2009. p. 613–26.

    Google Scholar 

  13. Citrome L. The ABC’s of dopamine receptor partial agonists – aripiprazole, brexpiprazole, and cariprazine: the 15-min challenge to sort these agents out. Int J Clin Pract. 2015;11:1211–20.

    Article  Google Scholar 

  14. Pillai A, Terry A, Mahadik SP. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res. 2006;82:95–106.

    Article  PubMed  Google Scholar 

  15. Nasrallah HA. Haloperidol is clearly neurotoxic: should it be banned. Curr Psychiatr Ther. 2013;12:7–9.

    Google Scholar 

  16. Nasrallah HA. A decade after the CATIE study, the focus has shifted to neuroprotection. Curr Psychiatr Ther. 2015;14:19–21.

    Google Scholar 

  17. Cohen LS, Viguera AC, McInerny KA, et al. Reproductive safety of second generation antipsychotics: current data from the Massachusetts General Hospital Pregnancy registry for atypical antipsychotics. Am J Psychiatr. 2016;173:263–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Chen MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chen, A., Nasrallah, H.A. (2018). Antipsychotics. In: Grossberg, G., Kinsella, L. (eds) Clinical Psychopharmacology for Neurologists. Springer, Cham. https://doi.org/10.1007/978-3-319-74604-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74604-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74602-9

  • Online ISBN: 978-3-319-74604-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics